The European Bank for Reconstruction and Development (EBRD) has agreed to provide a €6mn ($7.2mn) senior secured loan, with a year-and-a-half grace period, to Lamatem to support a new capex programme for the production of medical garments and single-use personal protective equipment, in response to changing markets demand caused by the coronavirus (COVID-19) pandemic.
Lamatem's existing facility that produces high-end medical garments was supported by a first EBRD loan to the tune of €7.7mn extended in 2019. The facility started operations in the third quarter of 2019, mainly as a toll manufacturer for Molnlycke, a leading global supplier of medical solutions based in Sweden. In response to the changing market environment, Lamatem has now launched a new capex programme to meet increasing demand from Moroccan clinics and its new European clients. The programme also includes new product segments which require a sterilisation process.
Lamatem is an export-oriented company established in 2016 near Casablanca to produce high-end medical garments, fully owned by the Badaa family. The total project cost for the existing and new facility is €20.7mn supported by €12.7mn financing from EBRD.
Related Articles
Saudi ACWA Power signs $2.3bn agreement to build 2GW wind power plant in Egypt
Saudi Arabia renewable energy firm ACWA Power has signed a 25-year power purchase agreement (PPA) with Egyptian Electricity Transmission Company (EETC) to develop, build, own, and operate a 2GW wind ... more
Sudan agrees to host Russian naval base in Port Sudan, says foreign minister
Sudan and Russia have reached a final agreement on establishing a Russian naval base in the Sudanese Red Sea coast, Sudan’s Foreign Minister Ali Yusuf Sharif said on February 12 as cited by Al ... more
Stellantis plans to produce 1,000 automated vehicles at Kenitra plant in Morocco
Global vehicles manufacturer Stellantis plans to produce 1,000 units annually of its Automated Guided Vehicles (AGVs) at the group’s Kenitra plant in Morocco, Al Maghrebia reported on February ... more
Most Read
-
Serbian biotech Dren Bio sold to Sanofi for $1.9bn
1 month ago
-
Scandal surrounding Hungarian central bank’s investments spreads to Polish developer GTC
29 days ago
-
Trump Ukraine envoy Witkoff dismisses Starmer’s Ukraine ceasefire plan, parrots Kremlin talking points
1 month ago
-
Israeli IDF troops engage in ground battle in Syria as airstrikes hit Palmyra
29 days ago
-
COMMENT: Why Iran remains wary of Trump's negotiation overtures
30 days ago